Boston Scientific Corp Stock Analysis

BSX Stock  USD 100.69  0.82  0.81%   
Boston Scientific Corp is overvalued with Real Value of 88.31 and Target Price of 99.42. The main objective of Boston Scientific stock analysis is to determine its intrinsic value, which is an estimate of what Boston Scientific Corp is worth, separate from its market price. There are two main types of Boston Scientific's stock analysis: fundamental analysis and technical analysis.
The Boston Scientific stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Boston Scientific is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Boston Stock trading window is adjusted to America/New York timezone.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Boston Stock Analysis Notes

About 93.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.98. Boston Scientific Corp had not issued any dividends in recent years. The entity had 2:1 split on the 6th of November 2003. Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts. Boston Scientific operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 41000 people. For more info on Boston Scientific Corp please contact Michael Mahoney at 508 683 4000 or go to https://www.bostonscientific.com.

Boston Scientific Quarterly Total Revenue

4.56 Billion

Boston Scientific Corp Investment Alerts

Boston Scientific is unlikely to experience financial distress in the next 2 years
Over 93.0% of the company shares are held by institutions such as insurance companies
Latest headline from zacks.com: PODD Stock Gains Following the Launch of Omnipod 5 in Australia

Boston Scientific Corp Upcoming and Recent Events

Earnings reports are used by Boston Scientific to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
31st of January 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
31st of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Boston Largest EPS Surprises

Earnings surprises can significantly impact Boston Scientific's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2013-10-24
2013-09-300.090.10.0111 
2013-04-25
2013-03-310.090.10.0111 
2012-07-26
2012-06-300.10.110.0110 
View All Earnings Estimates

Boston Scientific Environmental, Social, and Governance (ESG) Scores

Boston Scientific's ESG score is a quantitative measure that evaluates Boston Scientific's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Boston Scientific's operations that may have significant financial implications and affect Boston Scientific's stock price as well as guide investors towards more socially responsible investments.

Boston Scientific Thematic Classifications

In addition to having Boston Scientific stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Healthcare Idea
Healthcare
USA Equities from Healthcare industry as classified by Fama & French
Obamacare Repeal Idea
Obamacare Repeal
Large healthcare related equities associated with Obamacare

Boston Stock Institutional Investors

Shares
Bollard Group Llc2024-12-31
20.7 M
Morgan Stanley - Brokerage Accounts2024-12-31
20.5 M
Norges Bank2024-12-31
19.7 M
Massachusetts Financial Services Company2024-12-31
19.7 M
Franklin Resources Inc2024-12-31
16.5 M
Amvescap Plc.2024-12-31
15.8 M
Hhg Plc2024-12-31
15 M
Northern Trust Corp2024-12-31
14.6 M
Goldman Sachs Group Inc2024-12-31
12.9 M
Blackrock Inc2024-12-31
139 M
Vanguard Group Inc2024-12-31
132.9 M
Note, although Boston Scientific's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Boston Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 148.93 B.

Boston Profitablity

The company has Net Profit Margin of 0.11 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.17 %, which entails that for every 100 dollars of revenue, it generated $0.17 of operating income.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.12  0.12 
Return On Capital Employed 0.08  0.13 
Return On Assets 0.05  0.05 
Return On Equity 0.09  0.07 

Management Efficiency

Boston Scientific Corp has Return on Asset of 0.0504 % which means that on every $100 spent on assets, it made $0.0504 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0889 %, implying that it generated $0.0889 on every 100 dollars invested. Boston Scientific's management efficiency ratios could be used to measure how well Boston Scientific manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Boston Scientific's Return On Tangible Assets are fairly stable compared to the past year. Return On Capital Employed is likely to rise to 0.13 in 2025, whereas Return On Equity is likely to drop 0.07 in 2025. At this time, Boston Scientific's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 34.1 B in 2025, whereas Intangible Assets are likely to drop slightly above 5 B in 2025.
Last ReportedProjected for Next Year
Book Value Per Share 14.95  15.70 
Tangible Book Value Per Share(1.20)(1.26)
Enterprise Value Over EBITDA 54.46  57.19 
Price Book Value Ratio 6.04  5.90 
Enterprise Value Multiple 54.46  57.19 
Price Fair Value 6.04  5.90 
Enterprise Value61.2 B64.2 B
Leadership at Boston Scientific emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Operating Margin
0.1732
Profit Margin
0.1107
Beta
0.774
Return On Assets
0.0504
Return On Equity
0.0889

Technical Drivers

As of the 23rd of March, Boston Scientific shows the Downside Deviation of 1.76, risk adjusted performance of 0.1138, and Mean Deviation of 0.99. Boston Scientific Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Boston Scientific Corp Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Boston Scientific middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Boston Scientific Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Boston Scientific Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Boston Scientific insiders, such as employees or executives, is commonly permitted as long as it does not rely on Boston Scientific's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Boston Scientific insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Boston Scientific Outstanding Bonds

Boston Scientific issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Boston Scientific Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Boston bonds can be classified according to their maturity, which is the date when Boston Scientific Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Boston Scientific Predictive Daily Indicators

Boston Scientific intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Boston Scientific stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Boston Scientific Corporate Filings

19th of March 2025
Other Reports
ViewVerify
F4
5th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
3rd of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
26th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
25th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
24th of February 121225
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
21st of February 2025
Other Reports
ViewVerify
F4
19th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Boston Scientific Forecast Models

Boston Scientific's time-series forecasting models are one of many Boston Scientific's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Boston Scientific's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Boston Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Boston Scientific prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Boston shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Boston Scientific. By using and applying Boston Stock analysis, traders can create a robust methodology for identifying Boston entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.14  0.14 
Operating Profit Margin 0.16  0.10 
Net Profit Margin 0.11  0.12 
Gross Profit Margin 0.69  0.77 

Current Boston Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Boston analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Boston analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
99.42Strong Buy34Odds
Boston Scientific Corp current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Boston analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Boston stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Boston Scientific Corp, talking to its executives and customers, or listening to Boston conference calls.
Boston Analyst Advice Details

Boston Stock Analysis Indicators

Boston Scientific Corp stock analysis indicators help investors evaluate how Boston Scientific stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Boston Scientific shares will generate the highest return on investment. By understating and applying Boston Scientific stock analysis, traders can identify Boston Scientific position entry and exit signals to maximize returns.
Begin Period Cash Flow1.1 B
Long Term Debt8.8 B
Common Stock Shares Outstanding1.5 B
Total Stockholder Equity21.8 B
Tax Provision436 M
Quarterly Earnings Growth Y O Y0.12
Property Plant And Equipment Net3.3 B
Cash And Short Term Investments414 M
Cash414 M
Accounts Payable960 M
Net Debt10.3 B
50 Day M A101.3848
Total Current Liabilities6.4 B
Other Operating Expenses14.1 B
Non Current Assets Total32.5 B
Forward Price Earnings35.3357
Non Currrent Assets Other1.8 B
Stock Based Compensation266 M

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.